Bharat Biotech completes recruitment of 13,000 volunteers for Phase III trials of Covaxin
Bharat Biotech has signed up 13,000 volunteers for the Phase 3 trial,
backed by India's government medical research body, and is progressing
towards its goal of 26,000, the company said. The trial began in
mid-November at multiple sites across India.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-covid-19-vaccine-maker-says-recruitment-for-trials-on-track/articleshow/79853518.cms
backed by India's government medical research body, and is progressing
towards its goal of 26,000, the company said. The trial began in
mid-November at multiple sites across India.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/indian-covid-19-vaccine-maker-says-recruitment-for-trials-on-track/articleshow/79853518.cms
Comments
Post a Comment